J.Jpn. Surg. Soc.. 98(1): 41-45, 1997

---

Feature topic

CHEMOTHERAPY IN NON-SMALL CELL LUNG CANCER

Recent results of conibination chemotherapy for non-small cell lung cancer suggest modest survival benefits. Because combination chemotherapy can have severe side effets, it is reasonable to give chemotherapy when the patient is able to understand and accept the potential benefits and toxicities from such therapy. Recent randomized trials have shown survival benefit for chemotherapies before and after surgical resection. However, these have to be confirmed before they are recommended for general use. Because distant failure is common after radiation therapy for locally advanced non-small cell lung cancer, attempts have been made to improve suvival by adding chemotherapy to radiation therapy. The randomized trials comparing radiation with or without combination chemotherapy suggest a strong rational for exploring the combined use of the most effective chemotherapy regimens with more effective thoracic radiation approaches.

---

---

To read the PDF file you will need Adobe Reader installed on your computer.